BioMarin Pharmaceuticals
BMRN
BMRN
507 hedge funds and large institutions have $13.6B invested in BioMarin Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 193 increasing their positions, 165 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
507
Holders Change
-18
Holders Change %
-3.43%
% of All Funds
8.9%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
47
Increased
193
Reduced
165
Closed
57
Calls
$80.7M
Puts
$146M
Net Calls
-$65.7M
Net Calls Change
+$1.03M
Top Buyers
| 1 |
BlackRock
New York
|
$1.18B |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
$88.9M |
| 3 |
Millennium Management
New York
|
$65.6M |
| 4 |
Dodge & Cox
San Francisco,
California
|
$1.15B |
| 5 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
$45.7M |
